MEDIROM Plans Fiscal Year 2024 Financial Results Webcast
MEDIROM Healthcare Technologies will webcast its fiscal year 2024 financial results on May 21, 2025, at 8:30 AM ET.
Overview of MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc., a holistic healthcare company headquartered in Japan, will host a webcast on May 21, 2025, at 8:30 AM ET. This event will focus on the company’s financial results for the fiscal year ending December 31, 2024, following a press release scheduled for May 20, 2025. Recently, MEDIROM filed its annual report on Form 20-F, detailing its financials for 2024, which is accessible on the SEC website. The company operates 307 relaxation salons and has ventured into health technology through initiatives like the Lav® app and MOTHER Bracelet®. In 2023, it also launched REMONY, a remote monitoring system for various industries, aiming to excel in healthcare data management.
Positive Factors to Consider
- The forthcoming webcast will enhance transparency and provide a platform for stakeholder engagement.
- With 307 relaxation salons, MEDIROM demonstrates substantial operational scale and market presence in Japan.
- The introduction of healthcare products such as REMONY and MOTHER Bracelet reflects the company’s commitment to innovation and market expansion.
Concerns to Watch
- The press release includes several forward-looking statements, underscoring uncertainty around future financial performance and operations.
- Challenges in achieving profitability in the Digital Preventative Healthcare Segment could raise investor concerns.
- Various risks, including reliance on franchisee performance and capital-raising abilities, might impact the company’s operational effectiveness and growth prospects.
Frequently Asked Questions
When is MEDIROM’s financial results webcast?
The webcast is set for Wednesday, May 21, 2025, at 8:30 AM Eastern Time.
How can I access MEDIROM’s financial results report?
The financial report will be published after market close on Tuesday, May 20, 2025, and will be available on the SEC website.
What services does MEDIROM offer?
MEDIROM operates relaxation salons and provides healthcare solutions via its Lav® app and the MOTHER Bracelet®.
How can I participate in the webcast?
To join the webcast, visit the provided URL five to ten minutes before it starts and use the dial-in numbers.
What should I do to access the replay of the webcast?
The conference replay will be available from May 21 to June 4, 2025, through the dial-in numbers provided.
$MRM Hedge Fund Activity
In the most recent quarter, four institutional investors increased their shares in $MRM, while another four reduced their positions. Below are some notable activities:
- CITADEL ADVISORS LLC added 67,428 shares to their portfolio in Q1 2025, with an estimated value of $24,793.
- UBS GROUP AG increased their holdings by 53,110 shares, marking a 117.6% rise, valued at $19,528.
- HEIGHTS CAPITAL MANAGEMENT, INC removed 35,582 shares from their portfolio, valued at $13,083.
- WARBERG ASSET MANAGEMENT LLC eliminated 22,919 shares, with an estimated value of $8,427.
- VIRTU FINANCIAL LLC removed 10,942 shares in Q4 2024, resulting in an estimated value of $11,270.
- GAMMA INVESTING LLC added 4,917 shares in Q4 2024, with an estimated value of $5,064.
- XTX TOPCO LTD increased their holdings by 508 shares in Q1 2025, valued at $186.
$MRM Analyst Ratings
Recently, Wall Street analysts have issued reports regarding $MRM. One firm has issued a buy rating, while none have issued sell ratings. The most recent analyst action was a “Buy” rating from ThinkEquity on February 3, 2025.
Full Release
TOKYO, May 19, 2025 (GLOBE NEWSWIRE) —
MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM),
a holistic healthcare company based in Japan, will host a webcast to review the company’s fiscal year results ending December 31, 2024, on Wednesday, May 21, 2025, at 8:30 AM ET.
The company will issue a press release detailing those results after the market closes on Tuesday, May 20, 2025. Additionally, the latest annual report on Form 20-F is available on the SEC website and covers the company’s financial results for the 2024 fiscal year.
To access the webcast, please visit the URL below five to ten minutes before it starts:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=9rHZ3uFf
To join the webcast, dial in using the following numbers:
| North America (toll free): | 1-844-413-3971 |
| International: | 1-412-317-5775 |
| Japan (toll-free): | 0066-33-1-33094 |
Conference Replay: A replay will be available on May 21, 2025, at 11:30 a.m. ET until June 4, 2025, at 11:59 PM ET.
To access the replay, please dial:
| US (toll free): | 1-877-344-7529 |
| International (toll): | 1-412-317-0088 |
| Canada (toll free): | 855-669-9658 |
“`html
MEDIROM Healthcare Technologies Expands Offerings and Faces Future Risks
To access the replay using an international dial-in number, please select the following link:
https://services.choruscall.com/ccforms/replay.html
Company Overview
MEDIROM Healthcare Technologies Inc. operates 307 relaxation salons throughout Japan as of March 31, 2025. The company’s leading brand, Re.Ra.Ku
®, provides a range of healthcare services. MEDIROM entered the health tech arena in 2015 with the launch of its on-demand training app, “Lav
®.” This initiative aimed to broaden its offerings and enhance user engagement.
In 2020, MEDIROM expanded into the device sector, developing the “MOTHER Bracelet
®,” a smart health tracker. More recently, in 2023, the company introduced REMONY, a remote monitoring system tailored for corporate clients, receiving orders from various industries, including nursing care and transportation. Through these initiatives, MEDIROM seeks to collect and manage healthcare data effectively, aiming to position itself as a leader in healthcare big data.
For more information, visit medirom.co.jp/en.
Forward-Looking Statements
Certain statements in this press release are forward-looking, as defined by the U.S. Private Securities Litigation Reform Act of 1995. These statements may include estimates about the company’s operational results, financial health, and growth potential. Common indicators of forward-looking statements are terms like “may,” “will,” “expect,” and “project.”
Such statements concern future events and the company’s financial performance and can involve various risks and uncertainties that may affect actual results. Therefore, caution should be exercised to not place undue reliance on these statements.
Several factors could lead to actual results differing from expectations:
- Execution of the company’s growth strategies and development goals.
- Ability to sell owned salons to investors under acceptable terms.
- Changes in economic conditions that may impact expansion in Japan or abroad.
- Sustaining profitability within the Digital Preventative Healthcare Segment.
- Fluctuations in foreign exchange rates affecting expenses and liabilities.
- Ability to recruit and train sufficient therapists for salon operations.
- Impact of regional demographic and economic factors on salon performance.
- Maintaining brand value and protecting intellectual property.
- Performance of franchisees, which the company has limited control over.
- Ability to secure additional capital under favorable terms.
- Level of indebtedness affecting operational freedom.
- Shifts in consumer preferences and competitive dynamics.
- Response capabilities to natural disasters and global pandemics.
- Regulatory environment influencing business operations.
For additional details on risks and other factors that might influence the company’s performance, refer to the filings with the SEC, including the “Risk Factors” section of the company’s most recent Form 20-F and subsequent filings, available at www.sec.gov. MEDIROM assumes no obligation to update or revise any forward-looking statements.
Contact:
Investor Relations Team
“`
